Peripheral visual field thresholds using humphrey field analyzer program 60-4 in normal eyes

European Journal of Ophthalmology

Volumn 21, Issue 4, 2011, Pages 415-421

  Berezina, Tamara L ^a   Khouri, Albert S ^a   Kolomeyer, Anton M ^a   Clancy, Patrick S ^a   Fechtner, Robert D ^a  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

Eccentricity; Humphrey field analyzer; Peripheral visual field; Program 60 4

Indexed keywords

ADULT; AGED; ANALYZER; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; FUNCTION TEST; HUMAN; HUMAN EXPERIMENT; MALE; PERIPHERAL VISION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VISUAL ACUITY; VISUAL FIELD; VISUAL SYSTEM FUNCTION; VISUAL THRESHOLD;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SENSORY THRESHOLDS; VISION DISORDERS; VISUAL FIELD TESTS; VISUAL FIELDS; YOUNG ADULT;

EID: 79957822234     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/EJO.2011.6299     Document Type: Article

References (22)

1. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-79.
2. Drance SM. The Collaborative Normal-Tension Glaucoma Study and some of its lessons. Can J Ophthalmol 1999; 34: 1-6.
3. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 1999; 117: 573-83.
4. Lempert P. Reliability of visual fields in AGIS. Ophthalmology 1995; 102: 367-8.
5. Ardagil Akçkaya A, Göer S, Erbil HH, et al. Detecting retinal vigabatrin toxicity in patients with partial symptomatic or cryptogenic epilepsy. Eur J Ophthalmol 2010; 20: 763-9.
6. Fraunfelder FW. Ocular adverse drug reactions and the National Registry of Drug-Induced Ocular Side Effects. Insight 2004; 29: 7-11.
7. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramateassociated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology 2004; 111: 109-11.
8. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997; 314: 180-1.
9. Wild JM, Martinez C, Reinshagen G, Harding GF. Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia 1999; 40: 1784-94.
10. Käviänen R, Nousiainen I, Mäntyjävi M, et al. Vigabatrin, a GABAergic antiepileptic drug, causes concentric visual field defects. Neurology 1999; 53: 922-6.
11. Rucker JC, Hamilton SR, Bardenstein D, Isada CM, Lee MS. Linezolid-associated toxic optic neuropathy. Neurology 2006; 66: 595-8.
12. Tripathi RC, Tripathi BJ, Haggerty C. Drug-induced glaucomas: mechanism and management. Drug Saf 2003; 26: 749-67.
13. Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk. Drugs Aging 1999; 15: 439-50.
14. Jonas JB, Kreissig I, Degenring R. Secondary chronic openangle glaucoma after intravitreal triamcinolone acetonide. Arch Ophthalmol 2003; 121: 729-30.
15. Smithen LM, Ober MD, Maranan L, Spaide RF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 2004; 138: 740-3.
16. F abre-Guillevin E, Tchen N, Anibali-Charpiat MF, Calluaud L, Ravaud A. Taxane-induced glaucoma. Lancet 1999; 354: 1181-2.
17. Macaluso DC, Shults WT, Fraunfelder FT. Features of amiodarone- induced optic neuropathy. Am J Ophthalmol 1999; 127: 610-2.
18. F echtner RD, Khouri AS, Figueroa E, et al. Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results. Arch Ophthalmol 2006; 124: 1257-62.
19. Lewis RA, Johnson CA, Keltner JL, Labermeier PK. Variability of quantitative automated perimetry in normal observers. Ophthalmology 1986; 93: 878-81.
20. Katz J, Sommer A. A longitudinal study of the age-adjusted variability of automated visual fields. Arch Ophthalmol 1987; 105: 1083-6.
21. Heijl A, Lindgren G, Olsson J. The effect of perimetric experience in normal subjects. Arch Ophthalmol 1989; 107: 81-6.
22. Bengtsson B, Heijl A. Normal intersubject threshold variability and normal limits of the SITA SWAP and full threshold SWAP perimetric programs. Invest Ophthalmol Vis Sci 2003; 44: 5029-34.